Onco-Innovations Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2024	FY 2023
Period Ending	Jul '26 Jul 30, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Jan '24 Jan 31, 2024	Apr '23 Apr 30, 2023
Market Cap	39	72	57	-	-	-
Market Cap Growth	-63.67%	26.25%	-	-	-	-
Enterprise Value	38.05	71.33	56	0	0	0
Last Close Price	0.75	1.30	1.40	-	-	-
PS Ratio	351.80	653.29	874.80	-	-	-
PB Ratio	99.57	40.05	24.83	-	-	-
P/TBV Ratio	23.11	40.05	24.83	-	-	-
EV/Sales Ratio	-	646.26	857.77	-	-	-
Net Debt / Equity Ratio	-0.43	-0.43	-0.48	-	-	-1.00
Net Debt / EBITDA Ratio	0.07	0.07	0.24	-	-	79.13
Net Debt / FCF Ratio	0.15	0.15	0.29	-	-	79.47
Asset Turnover	0.09	0.06	0.05	0	0	0
Quick Ratio	0.98	0.98	2.94	-	-	-
Current Ratio	1.46	1.46	5.41	-	-	-
Return on Equity (ROE)	-980.15%	-981.79%	-837.65%	-695.25%	0.00%	-1.26%
Return on Assets (ROA)	-863.62%	-623.23%	-350.70%	-27.60%	0.00%	-1.26%
Return on Invested Capital (ROIC)	-2991.85%	-3107.62%	-818.16%	-28.75%	-	-
Return on Capital Employed (ROCE)	-1941.07%	-981.79%	-414.47%	-27.60%	0.00%	-1.26%
Buyback Yield / Dilution	-35.96%	-35.96%	-1071.62%	-	-	-
Total Shareholder Return	-35.96%	-35.96%	-1071.62%	-	-	-